Form 4: Quest Diagnostics Director Acquires Shares

Quest Diagnostics Director Gary M. Pfeiffer acquired 1,142 shares of common stock through an award of restricted stock units.

Summary

• Gary M. Pfeiffer, a Director at Quest Diagnostics Inc., acquired 1,142 shares of common stock on May 20, 2026.
• The acquisition was made through an award of restricted stock units.
• Following this transaction, Mr. Pfeiffer beneficially owns 31,005 shares of common stock directly.
• The filing also notes that the total amount includes shares acquired via dividend reinvestment under the company's Deferred Compensation Plan for Directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a director increasing their stake, which can be interpreted as confidence, but it is a routine disclosure without broader financial implications.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 1,142 shares by a director is a direct increase in beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common disclosures in the healthcare diagnostics sector. Such transactions can be viewed by the market as a positive signal regarding management's belief in the company's valuation and future performance.

Stakeholder Impact

• Shareholders: May view the director's acquisition positively as a sign of confidence in the company's future.
• Employees: May interpret the acquisition as a positive indicator of company stability and growth potential.
• Creditors: No direct impact from this transaction.

Key Dates

Keywords

Quest Diagnostics, DGX, Form 4, Insider Trading, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership